Psyence Biomedical Ltd.

NasdaqCM:PBM Stock Report

Market Cap: US$844.8k

Psyence Biomedical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Neil Maresky

Chief executive officer

US$356.7k

Total compensation

CEO salary percentage64.8%
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Neil Maresky's remuneration changed compared to Psyence Biomedical's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024US$357kUS$231k

-US$51m

Dec 31 2023n/an/a

-US$28m

Mar 31 2023US$311kUS$192k

-US$3m

Compensation vs Market: Neil's total compensation ($USD356.69K) is below average for companies of similar size in the US market ($USD651.40K).

Compensation vs Earnings: Neil's compensation has increased whilst the company is unprofitable.


CEO

Neil Maresky (59 yo)

less than a year

Tenure

US$356,686

Compensation

Dr. Neil Maresky, M.D. served as Chief Executive Officer at Psyence Group Inc. since July 1, 2021 and serves as its Director since December 09, 2021. He serves as Chief Executive Officer of Psyence Biomedi...


Board Members

NamePositionTenureCompensationOwnership
Jody Aufrichtig
Co-Founderless than a yearUS$185.00kno data
Neil Maresky
CEO & Director1.4yrsUS$356.69kno data
Seth Feuerstein
Independent Directorless than a yearno datano data
Marc Balkin
Independent Directorless than a yearno datano data
Christopher Bull
Independent Directorless than a yearno datano data

0.8yrs

Average Tenure

51yo

Average Age

Experienced Board: PBM's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.